Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators

被引：3

作者：

Solmi, Marco ^{[1
,2
,3
,4
,5
,6
]}

Croattog, Giovanni ^{[7
]}

Gupta, Arnav ^{[8
,9
]}

Fabianoa, Nicholas ^{[1
,6
]}

Wong, Stanley ^{[6
,10
]}

Fornaro, Michele ^{[11
]}

Schneiderl, Lynne Kolton ^{[12
]}

Rohani-Montez, S. Christy ^{[12
]}

Fairleyl, Leanne ^{[12
]}

Smithl, Nathalie ^{[12
]}

Bitterm, Istvan ^{[13
]}

Gorwoodn, Philip ^{[14
,15
]}

Taipalep, Heidi ^{[16
,17
,18
,19
]}

Tiihonenp, Jari ^{[16
,17
,18
]}

Cortese, Samuele ^{[20
,21
,22
,23
,24
]}

Dragioti, Elena ^{[25
,26
]}

Du Rietz, Ebba ^{[27
]}

Nielsen, Rene Ernst ^{[28
,29
]}

Firth, Joseph ^{[30
]}

Fusar-Poli, Paolo ^{[31
,32
,33
,34
]}

Hartman, Catharina ^{[35
]}

Holt, Richard I. G. ^{[36
]}

Hoye, Anne ^{[37
]}

Koyanagi, Ai ^{[38
,39
]}

Larsson, Henrik ^{[27
,40
]}

Lehto, Kelli ^{[41
]}

Lindgren, Peter ^{[42
,43
]}

Manchia, Mirko ^{[44
,45
,46
]}

Nordentoft, Merete ^{[47
]}

Skonieczna-Zydecka, Karolina ^{[48
]}

Stubbs, Brendon ^{[49
]}

Vancampfortay, Davy ^{[50
,51
]}

De Prisco, Michele ^{[52
]}

Boyer, Laurent ^{[53
]}

Vieta, Eduard ^{[52
]}

Correlle, Christoph U. ^{[54
,55
]}

机构：

[1] Univ Ottawa, Dept Psychiat, 501 Smyth Rd, Ottawa, ON, Canada

[2] Ottawa Hosp, Dept Mental Hlth, Ottawa, ON, Canada

[3] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada

[4] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada

[5] Charite, Dept Child & Adolescent Psychiat, Berlin, Germany

[6] Univ Ottawa, Dept Psychiat, Sci Lab, Ottawa, ON, Canada

[7] AULSS 3 Serenissima, Mental Hlth Dept, Venice, Italy

[8] Univ Calgary, Dept Med, Calgary, AB, Canada

[9] Kent State Univ, Coll Publ Hlth, Kent, OH USA

[10] Univ Toronto, Dept Psychiat, Toronto, ON, Canada

[11] Federico II Univ Naples, Dept Neurosci Reprod Sci & Dent, Sect Psychiat, Naples, Italy

[12] WebMD Global LLC, London, England

[13] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary

[14] Univ Paris Cite, Inst Psychiat & Neurosci Paris IPNP, INSERM, U1266, Paris, France

[15] St Anne Hosp, GHU Paris Psychiat & Neurosci CMME, Paris, France

[16] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden

[17] Stockholm City Council, Ctr Psychiat Res, Stockholm, Sweden

[18] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland

[19] Univ Eastern Finland, Sch Pharm, Kuopio, Finland

[20] Univ Southampton, Fac Environm & Life Sci, Ctr Innovat Mental Hlth, Sch Psychol, Southampton, England

[21] Solent NHS Trust, Southampton, England

[22] Univ Southampton, Fac Med, Clin & Expt Sci CNS & Psychiat, Southampton, England

[23] NYU, NYU Langone, Hassenfeld Childrens Hosp, Child Study Ctr, New York, NY USA

[24] Univ Bari Aldo Moro, DiMePRe J Dept Precis & Regenerat Med Jonic Area, Bari, Italy

[25] Linkoping Univ, Pain & Rehabil Ctr, Dept Med & Hlth Sci, Linkoping, Sweden

[26] Univ Ioannina, Sch Hlth Sci, Dept Nursing, Res Lab Psychol Patients Families & Hlth Profess, Ioannina, Greece

[27] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[28] Aalborg Univ, Dept Clin Med, Aalborg, Denmark

[29] Aalborg Univ Hosp, Dept Psychiat, Aalborg, Denmark

[30] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Psychol & Mental Hlth, Manchester, England

[31] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, Early Psychosis Intervent & Clin Detect EPIC Lab, London, England

[32] South London & Maudlsey SLaM NHS Fdn Trust, Outreach & Support South London OASIS Serv, London, England

[33] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy

[34] Ludwig Maximilian Univ LMU Hosp, Dept Psychiat & Psychotherapy, Munich, Germany

[35] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands

[36] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, England

[37] Univ Hosp Southampton NHS Fdn Trust, Southampton Natl Inst, Hlth Res Biomed Res Ctr, Southampton, England

[38] ISCIII, Res & Dev Unit, Parc Sanit St Joan Deu, CIBERSAM, 42 St Boi de Llobregat, Barcelona 08830, Spain

[39] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain

[40] Orebro Univ, Sch Med Sci, Orebro, Sweden

[41] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia

[42] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden

[43] Swedish Inst Hlth Econ, Lund, Sweden

[44] Univ Cagliari, Dept Med Sci & Publ Hlth, Sect Psychiat, Cagliari, Italy

[45] Univ Hosp Agcy Cagliari, Unit Clin Psychiat, Cagliari, Italy

[46] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada

[47] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Dept Clin Med, Copenhagen, Denmark

[48] Pomeranian Med Univ, Dept Biochem Sci, Szczecin, Poland

[49] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England

[50] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2024年 / 88卷

关键词：

Schizophrenia; Mortality; Cardiovascular; Cerebrovascular; Antipsychotic; Systematic review; SUBSTANCE USE DISORDERS; MYOCARDIAL-INFARCTION; REGIONAL DIFFERENCES; PSYCHIATRIC-PATIENTS; BIPOLAR DISORDER; STOCKHOLM COUNTY; ALL-CAUSE; DEATH; COHORT; NATIONWIDE;

D O I：

10.1016/j.euroneuro.2024.07.009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To further explore the role of different antipsychotic treatments for cardio-cerebrovascular mortality, we performed several subgroup, sensitivity and meta-regression analyses based on a large previous meta-analysis with schizophrenia, comparing antipsychotic treatment versus no antipsychotic. Quality assessment through the Newcastle-Ottawa Scale (NOS) and publication bias was measured. We meta-analyzed 53 different studies (schizophrenia patients: n = 2,513,359; controls: n = 360,504,484) to highlight the differential effects of antipsychotic treatment regimens on cardio-cerebrovascular-related mortality in incident and prevalent samples of tality in incident samples of schizophrenia (oral FGA [RR=2.20, 95 %CI=1.29-3.77, k = 1] and any FGA associated with reduced cardio-cerebrovascular-related mortality, in prevalent samples of schizophrenia. Subdemonstrated a larger association between antipsychotics and decreased risk of mortality with longer follow-up, recent study year, and higher number of adjustment variables. Overall, this subanalysis of a systematic review contributes to the evolving understanding of the complex role of antipsychotic treatment for cardiocerebrovascular mortality in schizophrenia, paving the way for more targeted interventions and improved pa

引用

页码：6 / 20

页数：15

共 50 条

[21] The Rising Relative Risk of Mortality for Singles: Meta-Analysis and Meta-Regression
Roelfs, David J.
Shor, Eran
Kalish, Rachel
Yogev, Tamar
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (04) : 379 - 389
[22] Severe mental illness and infectious disease mortality: a systematic review and meta-analysis
Ronaldson, Amy
Santana, Isabelle Nascimento
Carlisle, Sophie
Atmore, Katie H.
Chilman, Natasha
Heslin, Margaret
Markham, Sarah
Dregan, Alex
Das-Munshi, Jayati
Lampejo, Temi
Hotopf, Matthew
Bakolis, Ioannis
ECLINICALMEDICINE, 2024, 77
[23] Global mortality of children after perioperative cardiac arrest: A systematic review, meta-analysis, and meta-regression
Abate, Semagn Mekonnen
Nega, Solomon
Basu, Bivash
Tamrat, Kidanemariam
ANNALS OF MEDICINE AND SURGERY, 2022, 74
[24] Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis
Ni, Liwei
Wu, Jian
Long, Yuming
Tao, Jialong
Xu, Jianhao
Yuan, Xuya
Yu, Na
Wu, Runhong
Zhang, Yusong
BMC PSYCHIATRY, 2019, 19 (01)
[25] Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis
Ceraso, Anna
Lin, Jessie Jingxia
Schneider-Thoma, Johannes
Siafis, Spyridon
Heres, Stephan
Kissling, Werner
Davis, John M.
Leucht, Stefan
SCHIZOPHRENIA BULLETIN, 2022, 48 (04) : 738 - 740
[26] Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis
Vayisoglu, Sefa
Karahan, Sevilay
Anil Yagcioglu, A. Elif
TURK PSIKIYATRI DERGISI, 2019, 30 (04) : 253 - 259
[27] Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis
Jia, Ningning
Li, Zhijun
Li, Xinwei
Jin, Mengdi
Liu, Yane
Cui, Xingyao
Hu, Guoyan
Liu, Yang
He, Yang
Yu, Qiong
BRAZILIAN JOURNAL OF PSYCHIATRY, 2022, 44 (06) : 664 - 673
[28] Increased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression
Jirakran, Ketsupar
Almulla, Abbas F.
Jaipinta, Thapanee
Vasupanrajit, Asara
Jansem, Priabprat
Tunvirachaisakul, Chavit
Dzhambazova, Elizabet
Stoyanov, Drozdstoj St.
Maes, Michael
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2025, 169
[29] Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
Vermeulen, J.
van Rooijen, G.
Doedens, P.
Numminen, E.
van Tricht, M.
de Haan, L.
PSYCHOLOGICAL MEDICINE, 2017, 47 (13) : 2217 - 2228
[30] Loneliness, social isolation, and living alone: a comprehensive systematic review, meta-analysis, and meta-regression of mortality risks in older adults
Nakou, Agni
Dragioti, Elena
Bastas, Nikolaos-Stefanos
Zagorianakou, Nektaria
Kakaidi, Varvara
Tsartsalis, Dimitrios
Mantzoukas, Stefanos
Tatsis, Fotios
Veronese, Nicola
Solmi, Marco
Gouva, Mary
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 37 (01)

← 1 2 3 4 5 →